SCHEMBL7129217

SCHEMBL7129217

CC(C)(C)c1cc(C(=O)Nc2cccc(N)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.57
SMN1; SMN2 Q16637 2/20 0.55
MAPT P10636 1/20 0.55
ALDH1A1 P00352 3/20 0.53
DDX3X O00571 1/20 0.51
TOP1 P11387 1/20 0.51
TOP2A P11388 1/20 0.51
TOP2B Q02880 1/20 0.51
KCNK9 Q9NPC2 2/20 0.49
HDAC3 O15379 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
NR1H4 Q96RI1 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
SNCA P37840 1/20 0.46
GAA P10253 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KCNK3 O14649 2/20 0.45
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3660580 0.86 MEN1 (0.62) SMN1; SMN2MAPTALDH1A1TOP1TOP2A
SCHEMBL4319185 0.84 SNCA (0.65) PTGS1SMN1; SMN2MAPTALDH1A1TOP1
SCHEMBL9417262 0.83 MEN1 (0.62) SMN1; SMN2ALDH1A1TOP1TOP2ATOP2B
SCHEMBL26737633 0.82 DDX3X (0.69) PTGS1SMN1; SMN2MAPTALDH1A1DDX3X
SCHEMBL7301884 0.81 PTGS1 (0.74) PTGS1SMN1; SMN2MAPTALDH1A1DDX3X
SCHEMBL4652364 0.81 MEN1 (0.56) SMN1; SMN2MAPTALDH1A1TOP1TOP2A
SCHEMBL10316419 0.81 TOP1 (0.78) PTGS1SMN1; SMN2MAPTALDH1A1DDX3X
SCHEMBL9417400 0.80 NR1H4 (0.58) MAPTALDH1A1TOP1TOP2ATOP2B
SCHEMBL9321376 0.79 PTGS1 (0.61) PTGS1SMN1; SMN2MAPTALDH1A1DDX3X
SCHEMBL23997793 0.79 PTGS1 (0.58) PTGS1SMN1; SMN2MAPTALDH1A1DDX3X

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD PTGS1 313/4885SMN1; SMN2 3743/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.